Psychosocial and Patient Education Needs of Prostate Cancer Patients Selecting Watchful Waiting

January 18, 2018 updated by: David Latini, Baylor College of Medicine
This study includes an interview with men who have selected "watchful waiting" or "active surveillance" for their localized prostate cancer, in lieu of active treatment (such as surgery or radiation). We hope to understand the educational and support needs of men on surveillance so that we can develop a new intervention that will improve quality of life for such men.

Study Overview

Status

Completed

Detailed Description

Interviews are conducted over the telephone and require approximately 90 minutes to complete. Men interviewed are compensated for their participation in the study.

Study Type

Observational

Enrollment (Actual)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Texas
      • Houston, Texas, United States, 77030
        • Baylor College of Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Sampling Method

Non-Probability Sample

Study Population

Convenience sample of men on active surveillance drawn from large academic medical centers, community hospitals, support groups, and the internet.

Description

Inclusion Criteria:

  • 1) male,
  • 2) 18 years or older, with biopsy-proven prostate cancer,
  • 3) diagnosed with localized disease within the last 24 months,
  • 4) have a telephone at the time of enrollment,
  • 5) have an address where they can receive study materials by mail (a street address or post office box),
  • 6) able to speak and understand English;
  • 7) have selected surveillance, rather than active treatment for his prostate cancer.

Exclusion Criteria:

  • 1) female
  • 2) no diagnosis of localized prostate cancer
  • 3) completed or undergoing active treatment (e.g., surgery, radiotherapy, etc.)
  • 4) no phone or US mail address
  • 5) unwilling or unable to provide informed consent
  • 6) unable to speak and understand English

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
1
Observational cohort study

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Health-related quality of life, particularly cancer-specific anxiety and general anxiety
Time Frame: One time retrospective interview
One time retrospective interview

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: David M Latini, PhD, Baylor College of Medicine

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2007

Primary Completion (Actual)

October 1, 2009

Study Completion (Actual)

October 1, 2011

Study Registration Dates

First Submitted

July 16, 2008

First Submitted That Met QC Criteria

July 16, 2008

First Posted (Estimate)

July 17, 2008

Study Record Updates

Last Update Posted (Actual)

January 23, 2018

Last Update Submitted That Met QC Criteria

January 18, 2018

Last Verified

January 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • DLD2007-01

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Localized Prostate Cancer

Subscribe